Sistilli Carlo 4
4 · Edesa Biotech, Inc. · Filed Nov 6, 2020
Insider Transaction Report
Form 4
Sistilli Carlo
Director
Transactions
- Exercise of In-Money
Common shares
2020-11-05$4.00/sh+1,218$4,872→ 3,654 total(indirect: Held by York-Cav Enterprises, Inc.) - Exercise of In-Money
Common Share Warrants (Right to Buy)
2020-11-05−1,218→ 0 total(indirect: See footnote)Exercise: $4.00From: 2020-07-08Exp: 2020-11-08→ Common shares (1,218 underlying)
Footnotes (1)
- [F1]York-Cav Enterprises, Inc. is partially owned by the reporting party. Mr. Sistilli disclaims beneficial ownership except to the extent of his pecuniary interest therein.